328 related articles for article (PubMed ID: 8884775)
1. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
[TBL] [Abstract][Full Text] [Related]
3. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; Kehr J; Ungerstedt U; Terenius L
Brain Res; 1996 Feb; 710(1-2):241-8. PubMed ID: 8963665
[TBL] [Abstract][Full Text] [Related]
4. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
[TBL] [Abstract][Full Text] [Related]
5. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.
Bustamante D; You ZB; Castel MN; Johansson S; Goiny M; Terenius L; Hökfelt T; Herrera-Marschitz M
J Neurochem; 2002 Nov; 83(3):645-54. PubMed ID: 12390526
[TBL] [Abstract][Full Text] [Related]
6. Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides.
You ZB; Herrera-Marschitz M; Terenius L
J Pharmacol Exp Ther; 1999 Sep; 290(3):1307-15. PubMed ID: 10454508
[TBL] [Abstract][Full Text] [Related]
7. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
You ZB; Nylander I; Herrera-Marschitz M; O'Connor WT; Goiny M; Terenius L
Neuroscience; 1994 Nov; 63(2):415-25. PubMed ID: 7891855
[TBL] [Abstract][Full Text] [Related]
8. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
9. Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis.
You ZB; Saria A; Fischer-Colbrie R; Terenius L; Goiny M; Herrera-Marschitz M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):717-24. PubMed ID: 8971731
[TBL] [Abstract][Full Text] [Related]
10. Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis.
You ZB; Pettersson E; Herrera-Marschitz M; Hökfelt T; Terenius L; Nylander I; Goiny M; Hughes J; O'Connor WT; Ungerstedt U
Neuroreport; 1994 Nov; 5(17):2301-4. PubMed ID: 7881050
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
12. Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids.
Keefe KA; Sved AF; Zigmond MJ; Abercrombie ED
J Neurochem; 1993 Nov; 61(5):1943-52. PubMed ID: 7901337
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
[TBL] [Abstract][Full Text] [Related]
14. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.
Ge J; Long SK; Kilpatrick IC
Eur J Pharmacol; 1998 Mar; 345(2):163-70. PubMed ID: 9600632
[TBL] [Abstract][Full Text] [Related]
15. Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra.
Castro SL; Zigmond MJ
Brain Res; 2001 May; 901(1-2):47-54. PubMed ID: 11368949
[TBL] [Abstract][Full Text] [Related]
16. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
17. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.
Globus MY; Busto R; Dietrich WD; Martinez E; Valdes I; Ginsberg MD
J Neurochem; 1988 Nov; 51(5):1455-64. PubMed ID: 2902196
[TBL] [Abstract][Full Text] [Related]
18. Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat.
Smolders I; De Klippel N; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 1995 Sep; 284(1-2):83-91. PubMed ID: 8549640
[TBL] [Abstract][Full Text] [Related]
19. The release of amino acids from rat neostriatum and substantia nigra in vivo: a dual microdialysis probe analysis.
Bianchi L; Colivicchi MA; Bolam JP; Della Corte L
Neuroscience; 1998 Nov; 87(1):171-80. PubMed ID: 9722150
[TBL] [Abstract][Full Text] [Related]
20. Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine.
Roy E; Côté PY; Grégoire L; Parent A; Bédard PJ
Neuroscience; 1995 May; 66(2):413-25. PubMed ID: 7477882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
